Jack Geduldig

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Ejection Fraction

Venous Thromboembolism

Patient Reported Outcomes

Top Venues

BJU international

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jordan Miller Rich, Yuval Elkun, Jack Geduldig, Etienne Lavallee, Reza Mehrazin, Kyrollis Attalla, Peter Wiklund, John P Sfakianos
Outcomes From a Prospectively Implemented Protocol Using Apixaban After Robotic Radical Cystectomy. BJU international (2023)
Rifaquat Rahman, Lorenzo Trippa, Eudocia Quant Lee, Isabel C Arrillaga-Romany, Geoffrey Fell, Mehdi Touat, Christine McCluskey, Jennifer Wiley, Sarah Gaffey, Jan Drappatz, Mary R Welch, Evanthia Galanis, Manmeet S Ahluwalia, Howard Colman, Louis Burt Nabors, Jaroslaw Hepel, Heinrich Elinzano, David Schiff, Ugonma N Chukwueke, Rameen Beroukhim, Lakshmi Nayak, J Ricardo McFaline-Figueroa, Tracy T Batchelor, Mikael L Rinne, Thomas J Kaley, Christine Lu-Emerson, Ingo K Mellinghoff, Wenya Linda Bi, Omar Arnaout, Pier Paolo Peruzzi, Daphne A Haas-Kogan, Shyam Tanguturi, Daniel Cagney, Ayal A Aizer, Lisa Doherty, Maria Lavallee, Brittany Fisher-Longden, Shanna Dowling, Jack Geduldig, Fiona Watkinson, William Pisano, Seth Malinowski, Shakti Ramkissoon, Sandro Santagata, David M Meredith, E Antonio Chiocca, David A Reardon, Brian M Alexander, Keith L Ligon, Patrick Yung Wen
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)